124 related articles for article (PubMed ID: 35945747)
1. The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway.
Yu ZX; Xiang C; Xu SG; Zhang YP
Medicine (Baltimore); 2022 Aug; 101(31):e29972. PubMed ID: 35945747
[TBL] [Abstract][Full Text] [Related]
2. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
Liu Y; Yin Z; Wang Y; Chen H
Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
[TBL] [Abstract][Full Text] [Related]
3. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract][Full Text] [Related]
5. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
Front Immunol; 2022; 13():964891. PubMed ID: 36059514
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
[TBL] [Abstract][Full Text] [Related]
7. Prediction Biomarkers Associated with Lymph Node Metastasis and Prognosis were Identified in Papillary Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Gan S; Ye R; Ha Y; Xiong Y; Li R; Di X; Zou Z; Sun Y; Zhang Z
Comb Chem High Throughput Screen; 2021; 24(9):1395-1409. PubMed ID: 33155892
[TBL] [Abstract][Full Text] [Related]
8. FN1 Promotes Thyroid Carcinoma Cell Proliferation and Metastasis by Activating the NF-Κb Pathway.
Chen C; Shen Z
Protein Pept Lett; 2023; 30(1):54-64. PubMed ID: 36278453
[TBL] [Abstract][Full Text] [Related]
9. Favorable Prognostic Impact of Cathepsin H (CTSH) High Expression in Thyroid Carcinoma.
Peng P; Chen JY; Zheng K; Hu CH; Han YT
Int J Gen Med; 2021; 14():5287-5299. PubMed ID: 34522128
[TBL] [Abstract][Full Text] [Related]
10. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
11. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
12. Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.
Shuwen H; Xi Y; Miao D; Jiamin X; Jing Z; Weili G
Dis Markers; 2020; 2020():9369341. PubMed ID: 32626543
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the molecular features, relevant immune and clinical characteristics of
Hou X; Chen C; Lan X; He X
Front Immunol; 2022; 13():975787. PubMed ID: 36159823
[TBL] [Abstract][Full Text] [Related]
14. Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis.
Li CC; Ullah MHE; Lin X; Shan SK; Guo B; Zheng MH; Wang Y; Li F; Yuan LQ
Front Endocrinol (Lausanne); 2022; 13():948285. PubMed ID: 36120433
[TBL] [Abstract][Full Text] [Related]
15. Favorable function of Ectonucleoside triphosphate diphosphohydrolase 1 high expression in thyroid carcinoma.
Luo JH; Zhu YH; Xiang C
Hereditas; 2021 Aug; 158(1):33. PubMed ID: 34465393
[TBL] [Abstract][Full Text] [Related]
16. TTN mutations predict a poor prognosis in patients with thyroid cancer.
Han X; Chen J; Wang J; Xu J; Liu Y
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
[TBL] [Abstract][Full Text] [Related]
17. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma.
Zhang MM; Zhao YD; Li Q; He YJ
Histol Histopathol; 2023 Jun; 38(6):695-707. PubMed ID: 36409028
[TBL] [Abstract][Full Text] [Related]
19. E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
Lu JC; Zhang YP
Genet Mol Res; 2016 Mar; 15(1):15017576. PubMed ID: 26985959
[TBL] [Abstract][Full Text] [Related]
20. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
